Skip to main content

David Gorin, Robert Sprung

Premium
This week the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship Program for 2008 gave five recipients $138,000 each over three years to support research into early cancer detection.
 
Among the recipients are David Gorin at Harvard University, who is developing a new assay for the comparative analysis of protease activities in diseased and healthy tissues by “simultaneously investigating the activity of proteases on thousands of substrate peptides,” the Canary Foundation said in a statement.
 
Robert Sprung at the Vanderbilt-Ingram Cancer Center also was named a fellow. He is developing, standardizing, and applying a method for the proteomic analysis of formalin-fixed paraffin-embedded colon adema tissue.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.